TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Zivo Bioscience ( (ZIVO) ) is now available.
On August 12, 2025, Nola Masterson resigned from the Board of Directors of Zivo Bioscience, Inc., effective immediately, without any disagreements regarding the company’s operations, policies, or practices. Masterson, who served as chair of the Nominating and Governance committee and was a member of the Audit and Compensation committees, leaves a vacancy on the board, which has yet to be filled.
Spark’s Take on ZIVO Stock
According to Spark, TipRanks’ AI Analyst, ZIVO is a Underperform.
Zivo Bioscience faces significant financial challenges, including negative equity and cash flow issues, which are the primary factors in its low score. Despite some technical indicators showing neutrality, the company’s negative valuation metrics further impact the score. Urgent financial restructuring is necessary for sustainability.
To see Spark’s full report on ZIVO stock, click here.
More about Zivo Bioscience
Average Trading Volume: 1,214
Technical Sentiment Signal: Buy
Current Market Cap: $69.66M
See more insights into ZIVO stock on TipRanks’ Stock Analysis page.